Request A Call Back


Rizatriptan Benzoate
Inquiry Submitted Successfully

Rizatriptan Benzoate

  • Product Name : Rizatriptan Benzoate
  • Grade : IP / BP / USP
  • Therapeutic Category : Antimigraine
  • CAS No : 145202-66-0
  • COA : Available
  • MSDS : Available


Rizatriptan is FDA-approved to treat acute migraine attacks with or without aura. It does not prevent future migraine attacks. Rizatriptan is also used off-label to treat cluster headaches.


  • English name: Rizatriptan benzoate
  • Specification: 99%
  • CAS NO.:145202-66-0
  • Appearance: white crystalline powder
  • Molecular weight: 391.47
  • Molecular formula:C15H19N5






Content(dry base)


Loss on dry




Chloride-containing compounds


Heavy metals








Packaging details:



Packaging details:

25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.


Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat

Shelf Life:

5 years if sealed and store away from direct sun light.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.